|Articles|October 15, 2018
PAREXEL and Datavant Partner to Deliver Data and Real-World Evidence Analytics
Advertisement
PAREXEL and Datavant, Inc., a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets, announced they are partnering toward clinical study design and operations, as well as the generation of RWE. The collaboration hopes to enable the linking of healthcare data from a variety of real-world and clinical study data.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
3
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5